PNV 0.97% $2.05 polynovo limited

The Clinicians Speak, page-863

  1. 42 Posts.
    lightbulb Created with Sketch. 3
    This seems like a remarkable comparison of products, with so much coming out in favour of BTM.
    However, I wasn't sure what to make of the conclusion about economic differences. Seemed like it was a sales-driven article at first take. The authors did not state their postnominals, appointments or employers in the abstract title. Quite unusual in my experience/opinion.
    However, a little digging has me much more reassured.
    Timothy Olsen looks to be an MD candidate, doing a research paper: https://www.linkedin.com/in/timothy-olsen/
    Derek Bell seems to be a senior in plastic and orthopaedic surgeries at Rochester: https://www.urmc.rochester.edu/surgery/plastic/team/
    Safi Ali-Khan is listed as a resident physician at Rochester. https://www.linkedin.com/in/safi-ali-khan-a2bb61239/
    If this is all genuine info, then it gives a lot more credibility to the abstract IMO.
    bj.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.05
Change
-0.020(0.97%)
Mkt cap ! $1.414B
Open High Low Value Volume
$2.04 $2.07 $2.01 $2.692M 1.320M

Buyers (Bids)

No. Vol. Price($)
2 8476 $2.04
 

Sellers (Offers)

Price($) Vol. No.
$2.05 51937 4
View Market Depth
Last trade - 16.10pm 21/05/2024 (20 minute delay) ?
Last
$2.05
  Change
-0.020 ( 0.67 %)
Open High Low Volume
$2.06 $2.06 $2.01 236515
Last updated 15.59pm 21/05/2024 ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.